Related Experiment Video
Updated: Dec 25, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Experiences with end-of-life care with a left ventricular assist device: An integrative review
Jessica Harman Thompson1, Debra Moser1
1University of Kentucky, College of Nursing, 2201 Regency Road, Suite 403, Lexington, KY 40503, United States.
Abstract:
Left ventricular assist devices (LVAD) are increasingly being used to treat end-stage heart failure. Despite the increased prevalence of these devices, there is a still a high 1-year mortality rate. The purpose of this integrative review was to systematically evaluate research studies that focused on the process and content of LVAD related end-of-life discussions. A literature search was conducted from earliest available date to November, 2017. A total of 59 citations were produced, 13 articles went under full review, and six studies remained for inclusion in this review. Patients and their caregivers experienced confusion and frustration regarding the end-of-life experiences and care related to disjointed care by their provider teams. Clinician experiences and opinions also suggested a controversy about deactivation of the LVAD at the end-of-life, and a divide regarding practices at the end-of-life. Research focused on system-level factors involved in end-of-life care for patients with an LVAD is needed.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VII: Nursing Interventions
Heart Failure I: Introduction

